Double Bond Pharmaceutical International AB
Redevelops drugs with targeted delivery to improve safety and efficacy.
DBP B | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0007185517 (+1 more)
- LEI:
- 254900U1MWE2YSPREX74
- Country:
- Sweden
- Address:
- Virdings Alle 32B, 754 50 Uppsala
- Website:
- https://www.doublebp.com/
- Sector:
- Manufacturing
Description
Double Bond Pharmaceutical International AB is a pharmaceutical company that focuses on redeveloping established drugs into new formulations to improve safety and efficacy. The company's core strategy involves changing the route of administration and utilizing proprietary drug delivery technologies. Its main technology platform, BeloGal®, is a biomimetic encapsulation system designed for targeted drug delivery to specific organs, aiming to increase therapeutic effects while reducing systemic toxicity. The development pipeline is focused on treatments for high-need areas, including cancer and infectious diseases. Key candidates in the pipeline include SI-053, a locally administered temozolomide gel for glioblastoma; SA-033, a targeted doxorubicin formulation for liver cancer; and Belopenem, which directs the antibiotic meropenem to the lungs to treat pneumonia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Double Bond Pharmaceutical International AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Double Bond Pharmaceutical International AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Double Bond Pharmaceutical International AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
